ID   HUG-31
AC   CVCL_VR07
SY   HUG31
DR   IARC_TP53; 6265
DR   Wikidata; Q94308460
RX   PubMed=8707423;
RX   PubMed=9614553;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Gly (c.482C>G); Zygosity=Heterozygous (PubMed=8707423).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
RX   PubMed=8707423; DOI=10.1002/(SICI)1097-0215(19960729)67:3<447::AID-IJC22>3.0.CO;2-3;
RA   Tada M., Iggo R.D., Ishii N., Shinohe Y., Sakuma S., Estreicher A.,
RA   Sawamura Y., Abe H.;
RT   "Clonality and stability of the p53 gene in human astrocytic tumor
RT   cells: quantitative analysis of p53 gene mutations by yeast functional
RT   assay.";
RL   Int. J. Cancer 67:447-450(1996).
//
RX   PubMed=9614553; DOI=10.1038/sj.gt.3300605;
RA   Tada M., Sakuma S., Iggo R.D., Saya H., Sawamura Y., Fujiwara T.,
RA   Roth J.A.;
RT   "Monitoring adenoviral p53 transduction efficiency by yeast functional
RT   assay.";
RL   Gene Ther. 5:339-344(1998).
//